Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose Aspirin for Idiopathic Asymmetrical IUGR
NCT03038607Phase 2Completed
- Sponsor
- Assiut University
- Start
- Jan 2016
- Primary completion
- Jan 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of aspirin in intrauterine growth restriction (IUGR), sponsored by Assiut University. Started Jan 2016; status: completed.
02
Drugs
aspirin
03
Conditions
intrauterine growth restriction (IUGR)
Beyond the preview
Go deeper on NCT03038607.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03038607.